Genus PLC
LSE:GNS

Watchlist Manager
Genus PLC Logo
Genus PLC
LSE:GNS
Watchlist
Price: 1 696 GBX 0.95% Market Closed
Market Cap: 1.1B GBX
Have any thoughts about
Genus PLC?
Write Note

Genus PLC
Common Shares Outstanding

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Genus PLC
Common Shares Outstanding Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Common Shares Outstanding CAGR 3Y CAGR 5Y CAGR 10Y
Genus PLC
LSE:GNS
Common Shares Outstanding
ÂŁ66m
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
1%
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
Common Shares Outstanding
$98.8m
CAGR 3-Years
4%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Exscientia PLC
NASDAQ:EXAI
Common Shares Outstanding
ÂŁ125.7m
CAGR 3-Years
2%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Autolus Therapeutics PLC
NASDAQ:AUTL
Common Shares Outstanding
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bicycle Therapeutics PLC
NASDAQ:BCYC
Common Shares Outstanding
$69m
CAGR 3-Years
39%
CAGR 5-Years
31%
CAGR 10-Years
N/A
Immunocore Holdings PLC
NASDAQ:IMCR
Common Shares Outstanding
ÂŁ49.7m
CAGR 3-Years
6%
CAGR 5-Years
3%
CAGR 10-Years
N/A
No Stocks Found

Genus PLC
Glance View

Market Cap
1.1B GBX
Industry
Biotechnology

Genus Plc engages in the provision of genetic livestock services to produce meat and milk. The company is headquartered in Basingstoke, Hampshire and currently employs 3,096 full-time employees. The company went IPO on 2000-07-06. The firm provides farmers with genetics that enable them to produce animal protein for breeding pigs and cattle, in the form of meat and milk. The Company’s operating segments includes Genus PIC, Genus ABS and Research and Development. The Genus PIC segment is engaged in porcine sales business. The Genus ABS segment is engaged in bovine sales business. The firm's development activities include developing and maintaining its porcine genetic nucleus herd and bovine pre-stud herds. The firm operates approximately around 25 countries on six continents, with research laboratories located in Madison, Wisconsin, United States.

GNS Intrinsic Value
2 051.37 GBX
Undervaluation 17%
Intrinsic Value
Price

See Also

What is Genus PLC's Common Shares Outstanding?
Common Shares Outstanding
66m GBP

Based on the financial report for Jun 30, 2024, Genus PLC's Common Shares Outstanding amounts to 66m GBP.

What is Genus PLC's Common Shares Outstanding growth rate?
Common Shares Outstanding CAGR 10Y
1%

Over the last year, the Common Shares Outstanding growth was 0%.

Back to Top